Recombinant L Monocytogenes as an SIV Vaccine - Andrew Kaplan

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research Project (R01)
Project #: 7R01AI039427-03
Application #: 6028315
Study Section: AIDS and Related Research Study Section 1 (ARRA)

Project Start: 1996-09-30
Project End: 2000-11-30
Budget Start: 1998-05-01
Budget End: 1998-11-30
Support Year: 3
Fiscal Year: 1998
Total Cost
Indirect Cost

Institution

Name: University of North Carolina Chapel Hill
Department: Internal Medicine/Medicine
Type: Schools of Medicine
DUNS #: 078861598

City: Chapel Hill
State: NC
Country: United States
Zip Code: 27599

Related projects


NIH 2000 R01 AI	Recombinant L Monocytogenes as an SIV Vaccine Kaplan, Andrew H. / University of North Carolina Chapel Hill	$265,494
NIH 1999 R01 AI	Recombinant L Monocytogenes as an SIV Vaccine Kaplan, Andrew H. / University of North Carolina Chapel Hill
NIH 1998 R01 AI	Recombinant L Monocytogenes as an SIV Vaccine Kaplan, Andrew H. / University of California Los Angeles
NIH 1998 R01 AI	Recombinant L Monocytogenes as an SIV Vaccine Kaplan, Andrew H. / University of North Carolina Chapel Hill
NIH 1997 R01 AI	Recombinat L. Monocytogenes as an SIV Vaccine Kaplan, Andrew H. / University of California Los Angeles

Comments

Be the first to comment on Andrew Kaplan's grant